申请人:Dana Farber Cancer Institute, Inc.
公开号:EP3799871A2
公开(公告)日:2021-04-07
This application features pyrazol-3-one compounds that activate pro-apoptotic BAX. Also featured are methods of using such compounds, e.g., for the treatment or prevention of diseases, disorders, and conditions associated with deregulated apoptosis of cells (e.g., insufficient apoptosis of diseased or damaged cells or essentially the absence of apoptosis of diseased or damaged cells).
本申请的特点是吡唑-3-酮化合物能激活促细胞凋亡的 BAX。此外,还介绍了使用此类化合物的方法,例如,用于治疗或预防与细胞凋亡失调(例如,病变或受损细胞凋亡不足或病变或受损细胞基本上没有凋亡)有关的疾病、失调和病症。